Found 173 matching trials
Buprenorphine Transdermal Patches Pharmacokinetic Study PHASE1 This is an open-label, randomised, single-dose, 3 arms study design....
Location
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Learn More & Join Trial
Extended Release Naltrexone for Opioid-Dependent Youth PHASE4 The purpose of this study is to compare 6-month treatment outcomes for 15-2...
Show More Location
Friends Research Institute
Learn More & Join Trial
Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia PHASE1 The purpose of this study is to assess the feasibility and safety of inject...
Show More Location
The University of Texas health Science Center at Houston
Learn More & Join Trial
Buprenorphine Naltrexone-P1 A-Cocaine PHASE1 The purpose of this study is to determine if the opioid agonist effects of ...
Show More Location
Drug Dependence Research Center
Learn More & Join Trial
Comparison of Three Opioid Detoxification Treatment Regimens PHASE3 Despite an increased focus on treating opioid use disorder there are relati...
Show More Location
Virginia Commonwealth University
Learn More & Join Trial
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone PHASE4 Interstitial cystitis/painful bladder syndrome (IC/PBS) is a debilitating c...
Show More Location
Center for Pelvic Health at the NorthShore University HealthSystem
Learn More & Join Trial
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101) PHASE1 PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Show More Location
PRA Health Sciences - Early Development Services
Learn More & Join Trial
Sweet Preference and Alcohol Craving PHASE2 Purpose: The proposed 2-year investigation will be the first double-blind, ...
Show More Location
University of North Carolina - Chapel Hill
Learn More & Join Trial
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain PHASE3 The primary objective of the study is to determine the analgesic efficacy a...
Show More Location
Coastal Clinical Research, Inc.
Learn More & Join Trial
Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia PHASE2 Oral naltrexone was initially FDA approved to treat opioid use disorder and...
Show More Location
Washington University
Learn More & Join Trial